课题基金 / 基金详情

CALIFORNIA NEUROAIDS TISSUE NETWORK (CNTN)

CALIFORNIA NEUROAIDS TISSUE NETWORK (CNTN)
加州神经艾滋病组织网络 (CNTN)
批准号:
8174523
负责人:
ERIC S DAAR
金额:
$11.14万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-11-30

项目摘要

项目成果

ERIC S DAAR的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这是一项修订后的议定书,将继续研究5年以上。加州神经艾滋病组织网络(CNTN)是由三个加州医学中心(加州大学圣地亚哥分校、加州大学欧文分校和加州大学洛杉矶分校海港分校)组成的联盟,旨在收集艾滋病患者的神经学标本。CNTN的港湾-UCLA部分旨在识别、招募、招募和评估约85名预期寿命不到一年的患者,其中约6人每年将接受尸检。这些患者中的大多数是在过去8年中入选的。患者在死亡或丢失时将被替换,以维持70名患者的队列。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an amended protocol to continue study for 5 more years. The California NeuroAIDS Tissue Network (CNTN) is a consortium of three Californian Medical Centers (UC San Diego, UC Irvine, and Harbor-UCLA) which proposes to collect neurologic specimens from AIDS patients. Harbor-UCLA component of CNTN is designed to identify, recruit, enroll, and assess a cohort of approximately 85 patients with life expectancies of less than one year of whom about 6 will be autopsied each year. The majority of these patients have been enrolled during the past 8 years. Patients will be replaced as they die or are lost to follow up to mantain a cohort of 70 patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
CLINICAL TRIAL: A PHASE III COMPARATIVE STUDY OF THREE NON-NUCLEOSIDE REVERSE TR
海外基金